BSE
NSE

NSE Prices delayed by 15 minutes ! Prices as on Sep 21, 2026 - 3:31PM

ABB India 7256 [ -0.20% ]
ACC 1257 [ -0.21% ]
Ambuja Cements 392 [ 0.95% ]
Asian Paints 2450 [ -0.05% ]
Axis Bank 1248 [ -0.72% ]
Bajaj Auto 11510 [ 0.84% ]
Bank of Baroda 234.19 [ -0.32% ]
Bharti Airtel 1831.4 [ -3.27% ]
Bharat Heavy 434.8 [ -1.16% ]
Bharat Petroleum 312.55 [ -0.46% ]
Britannia Industries 5021 [ 0.46% ]
Cipla 1379 [ -1.11% ]
Coal India 413.4 [ 0.85% ]
Colgate Palm 1880 [ -1.97% ]
Dabur India 388.1 [ -1.81% ]
DLF 660.3 [ 2.48% ]
Dr. Reddy's Lab. 1202 [ 1.43% ]
GAIL (India) 172.76 [ -0.66% ]
Grasim Industries 3170 [ -1.22% ]
HCL Technologies 1281 [ 2.54% ]
HDFC Bank 740.5 [ 1.30% ]
Hero MotoCorp 5412 [ 2.39% ]
Hindustan Unilever 1951 [ 0.98% ]
Hindalco Industries 977.2 [ -0.94% ]
ICICI Bank 1345.6 [ 0.50% ]
Indian Hotels Co. 746 [ 1.81% ]
IndusInd Bank 958.5 [ -0.81% ]
Infosys 1040.5 [ -1.04% ]
ITC 267.45 [ 1.96% ]
Jindal Steel 1136 [ 1.47% ]
Kotak Mahindra Bank 415.3 [ 0.68% ]
L&T 3896 [ 0.28% ]
Lupin 2125 [ 2.02% ]
Mahi. & Mahi 3060.7 [ 0.29% ]
Maruti Suzuki India 12165 [ 0.51% ]
MTNL 23.65 [ -0.63% ]
Nestle India 1389.8 [ 1.27% ]
NIIT 90.79 [ -0.85% ]
NMDC 80.36 [ 1.53% ]
NTPC 326.5 [ 0.88% ]
ONGC 235.25 [ 1.05% ]
Punj. NationlBak 118.1 [ 0.71% ]
Power Grid Corpn. 267 [ -1.22% ]
Reliance Industries 1246.4 [ 1.63% ]
SBI 996 [ -0.02% ]
Vedanta 259.4 [ -3.06% ]
Shipping Corpn. 280.75 [ 1.34% ]
Sun Pharmaceutical 1875 [ 2.05% ]
Tata Chemicals 694.85 [ 0.23% ]
Tata Consumer 1005.9 [ 0.99% ]
Tata Motors Passenge 301.15 [ -0.87% ]
Tata Steel 183.7 [ -0.99% ]
Tata Power Co. 366.85 [ -2.12% ]
Tata Consult. Serv. 2133.2 [ 1.34% ]
Tech Mahindra 1555 [ 1.16% ]
UltraTech Cement 11100 [ 0.78% ]
United Spirits 1404.3 [ 2.43% ]
Wipro 165.2 [ -0.98% ]
Zee Entertainment 77.62 [ -1.27% ]

Partner with US

Open an Demat Account

Portfolio Tracker

News Details
Home

News Details

17/09/2026 10:52

Back

Alkem Laboratories launches Epilepsy Drug NeuCeno in India

Alkem Laboratories on Wednesday announced the launch of NeuCeno (cenobamate) in India for the treatment of partial-onset seizures in adult patients.

The company said cenobamate is being introduced in India for the first time, where an estimated 94 lakh people are living with epilepsy. NeuCeno is a once-daily oral therapy available in tablet strengths ranging from 12.5 mg to 200 mg.